Other Species / Isoforms
  FCGR2B iso2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
N180
KFSRSDPNFSIPQAN
0 1
FCGR2B (human) KFSRSDPNFSIPQAN N180
FCGR2B iso2 (human) KFSRSDPNFSIPQAN N180
FCGR2B (mouse) RYHHYSSnFSIPKAN N166-ng
FCGR2B iso2 (mouse) RYHHYSSNFSIPKAN N166
FCGR2B (rat) RYYHQSSNFSIPKAN N168
A243
AIVAAVVALIYCRKK
0 1
FCGR2B (human) AIVAAVVALIYCRKK A243
FCGR2B iso2 (human) AIVAAVVALIYCRKK A243
FCGR2B (mouse) AIVIILVsLVyLKKK S232-p
FCGR2B iso2 (mouse) AIVIILVSLVYLKKk S232
FCGR2B (rat) AIVIILVSLVYLKKK S234
Y246
AAVVALIYCRKKRIs
1 0
FCGR2B (human) AAVVALIYCRKKRIS Y246
FCGR2B iso2 (human) AAVVALIYCRKKRIs Y246
FCGR2B (mouse) IILVsLVyLKKKQVP Y235-p
FCGR2B iso2 (mouse) IILVSLVYLKKkQVP Y235
FCGR2B (rat) IILVSLVYLKKKQVP Y237
K250
ALIYCRKKRIsANPT
0 1
FCGR2B (human) ALIYCRKKRISALPG K250
FCGR2B iso2 (human) ALIYCRKKRIsANPT K250
FCGR2B (mouse) sLVyLKKKQVPALPG K239
FCGR2B iso2 (mouse) SLVYLKKkQVPDNPP K239-ub
FCGR2B (rat) SLVYLKKKQVPDTPs K241
S253-p
YCRKKRIsANPTNPD
0 1
FCGR2B (human) YCRKKRISALPGYPE S253
FCGR2B iso2 (human) YCRKKRIsANPTNPD S253-p
FCGR2B (mouse) yLKKKQVPALPGNPD P242
FCGR2B iso2 (mouse) YLKKkQVPDNPPDLE P242
FCGR2B (rat) YLKKKQVPDTPsGLE P244
-
gap
1 0
FCGR2B (human) gap -
FCGR2B iso2 (human) gap -
FCGR2B (mouse) LPEEVGEyRQPSGGS Y264-p
FCGR2B iso2 (mouse) gap -
FCGR2B (rat) gap -
-
gap
0 1
FCGR2B (human) gap -
FCGR2B iso2 (human) gap -
FCGR2B (mouse) PVSPGPPSGLEPTSS S280
FCGR2B iso2 (mouse) gap -
FCGR2B (rat) KQVPDTPsGLEEAEK S248-p
A254
CRKKRIsANPTNPDE
1 0
FCGR2B (human) ETLPEKPANPTNPDE A273
FCGR2B iso2 (human) CRKKRIsANPTNPDE A254
FCGR2B (mouse) EPTSSSPyNPPDLEE Y290-p
FCGR2B iso2 (mouse) LKKkQVPDNPPDLEE D243
FCGR2B (rat) gap -
Y273-p
GAENTITySLLMHPD
Upstream
Downstream
4 3
Effects on Modified Protein
  • molecular association, regulation
Treatment
  • beta-amyloid_42
FCGR2B (human) GAENTITysLLMHPD Y292-p
FCGR2B iso2 (human) GAENTITySLLMHPD Y273-p
FCGR2B (mouse) EAENTITySLLkHPE Y309-p
FCGR2B iso2 (mouse) EAENTITYSLLKHPE Y262
FCGR2B (rat) EVENTITYSLLKHPE Y264
S274
AENTITySLLMHPDA
0 2
FCGR2B (human) AENTITysLLMHPDA S293-p
FCGR2B iso2 (human) AENTITySLLMHPDA S274
FCGR2B (mouse) AENTITySLLkHPEA S310
FCGR2B iso2 (mouse) AENTITYSLLKHPEA S263
FCGR2B (rat) VENTITYSLLKHPEA S265
M277
TITySLLMHPDALEE
0 1
FCGR2B (human) TITysLLMHPDALEE M296
FCGR2B iso2 (human) TITySLLMHPDALEE M277
FCGR2B (mouse) TITySLLkHPEALDE K313-ub
FCGR2B iso2 (mouse) TITYSLLKHPEALDE K266
FCGR2B (rat) TITYSLLKHPEAPDE K268
-
gap
0 1
FCGR2B (human) gap -
FCGR2B iso2 (human) gap -
FCGR2B (mouse) PEALDEETEHDyQNH T322
FCGR2B iso2 (mouse) PEALDEETEHDYQNH T275
FCGR2B (rat) PEAPDEEsDHDYQNH S277-p
D287
DALEEPDDQNRI___
1 11
FCGR2B (human) DALEEPDDQNRI___ D306
FCGR2B iso2 (human) DALEEPDDQNRI___ D287
FCGR2B (mouse) DEETEHDyQNHI___ Y326-p
FCGR2B iso2 (mouse) DEETEHDYQNHI___ Y279
FCGR2B (rat) DEEsDHDYQNHI___ Y281